https://scholars.lib.ntu.edu.tw/handle/123456789/536142
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | WANG-HUEI SHENG | en_US |
dc.contributor.author | WANG-DA LIU | en_US |
dc.contributor.author | JANN-TAY WANG | en_US |
dc.contributor.author | Chang S.-Y. | en_US |
dc.contributor.author | SHAN-CHWEN CHANG | en_US |
dc.creator | Sheng W.-H.;Liu W.-D.;Wang J.-T.;Chang S.-Y.;Shan-Chwen Chang | - |
dc.date.accessioned | 2020-12-30T02:45:22Z | - |
dc.date.available | 2020-12-30T02:45:22Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 0929-6646 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094961405&doi=10.1016%2fj.jfma.2020.10.003&partnerID=40&md5=250a0b5de1ef7dda363bd694e0f56c17 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/536142 | - |
dc.description.abstract | Background/Purpose: To investigate the characteristics of dysosmia and dysgeusia among patients diagnosed with coronavirus disease 2019 (COVID-19) in Taiwan. Methods: Prospective data collection between January 22, 2020 to May 7, 2020 of nucleic acid confirmed COVID-19 hospitalized patients in northern Taiwan by the Taiwan Centers for Disease Control were analyzed. Results: Of 217 patients enrolled, 78 (35.9%) reported dysosmia (n = 73, 33.6%) and/or dysgeusia (n = 62, 28.6%). The median duration of COVID-19 associated symptom-onset to development of dysosmia and/or dysgeusia was <1 days (interquartile range [IQR], <1–6 days) and 53 of 78 (67.9%) patients developed dysosmia and/or dysgeusia as one of the initial symptoms of COVID-19. Of 59 closely monitored patients, 41 (69.5%) patients recovered within 3 weeks after symptoms onset and the median time to recovery was 12 days (IQR, 7–20 days). Only 6 of the 59 (10.2%) patients reported persistent dysosmia and/or dysgeusia before discharge from hospitals. Multivariate analysis showed that younger individuals (adjusted hazard ratio [AHR], 0.93 per one-year increase; 95% confidence interval [95% CI], 0.89–0.97; P = 0.001), women (AHR, 2.76; 95% CI, 1.05–7.25; P = 0.04) and travel to North America (AHR, 2.35; 95% CI, 1.05–5.26; P = 0.04) were the significant factors associated with dysosmia and/or dysgeusia. Conclusion: Dysosmia and/or dysgeusia are common symptoms and clues for the diagnosis of COVID-19, particularly in the early stage of the disease. Physicians should be alerted to these symptoms to make timely diagnosis and management for COVID-19 to limit spread. ? 2020 Formosan Medical Association | - |
dc.publisher | Elsevier B.V. | - |
dc.relation.ispartof | Journal of the Formosan Medical Association | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | azithromycin; hydroxychloroquine; lopinavir plus ritonavir; remdesivir; adult; Article; confidence interval; controlled study; coronavirus disease 2019; dysgeusia; dysosmia; female; hazard ratio; human; information processing; major clinical study; male; Taiwan; travel; case control study; complication; dysgeusia; early diagnosis; hospitalization; middle aged; prognosis; prospective study; risk factor; smelling disorder; Taiwan; virology; Adult; Case-Control Studies; COVID-19; COVID-19 Testing; Dysgeusia; Early Diagnosis; Female; Hospitalization; Humans; Male; Middle Aged; Olfaction Disorders; Prognosis; Prospective Studies; Risk Factors; Taiwan | - |
dc.title | Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.jfma.2020.10.003 | - |
dc.identifier.pmid | 33139151 | - |
dc.relation.pages | 311-317 | - |
dc.relation.journalvolume | 120 | - |
dc.relation.journalissue | 1 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Medical Education-NTUH | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Medicine-NTUCC | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Center for Infection Control | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Office of the Vice President | - |
crisitem.author.dept | Clinical Pharmacy | - |
crisitem.author.dept | Medical Education and Bioethics | - |
crisitem.author.orcid | 0000-0002-5605-7853 | - |
crisitem.author.orcid | 0000-0001-6058-6224 | - |
crisitem.author.orcid | 0000-0002-0924-3469 | - |
crisitem.author.orcid | 0000-0001-6505-4139 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | Administrative Unit | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。